Literature DB >> 26959941

Single-Incision Laparoscopy Could Be Better than Standard Laparoscopy in Right Colectomy for Cancer.

Elie Chouillard1, Salman Alsabah2, Ronald Daher1, Antoine Younan3, Vincenzo James Greco4, Elias Chahine1, Bassam Abdullah1, Jean Biagini5.   

Abstract

BACKGROUND: Human natural orifice transluminal endoscopic surgery (NOTES) is slowed down by technical hurdles. Concomitantly, single-incision laparoscopy has been increasingly reported as an alternative. By reducing the invasiveness of standard laparoscopy, we may further reduce postoperative pain, decrease morbidity, preserve abdominal wall, and enhance cosmesis. Such techniques have been widely applied, including in colorectal surgery. The aim of this multicenter study is to compare the results of single-incision right colectomy (SIRC) with the results of the standard laparoscopic right colectomy (SLRC) in patients with colon cancer.
METHODS: The files of patients who underwent right colectomy for cancer in five hospitals between January 2010 and December 2013 have been reviewed. Exclusion criteria were open surgery, emergency setting, and American Society of Anesthesiologists (ASA) score >3. Patients were distributed in Groups A (SIRC) or B (SLRC).
RESULTS: Five hundred ninety-two patients were included in this study, 336 in Group A and 256 in Group B. Mean operative time was 129.0 minutes (range 65-245) in Group A and 168.1 minutes in the Group B (range 70-290), respectively (P < .001). No mortality occurred in either group. The overall 30-day morbidity rates were 21.4% in Group A and 25% in Group B, respectively (P = .64). The median length of hospital stay was 4.95 days (range 3-14) in Group A and 5.5 days in Group B (range 3-12), respectively (P = .28). Conversion to laparotomy occurred in four patients in each group (P = 1). Length of skin incision was significantly shorter in Group A than in Group B (2.99 ± 0.63 cm versus 4.94 ± 0.65 cm, P < .001). Histological analysis of the operative specimens showed no significant differences.
CONCLUSION: SIRC is feasible and sure for patients with colon cancer. As compared with SLRC, SIRC may offer some advantages, including lower operative morbidity, shorter hospital stay, and better cosmoses, without compromising the oncological quality of the resected specimen.

Entities:  

Mesh:

Year:  2016        PMID: 26959941     DOI: 10.1089/lap.2015.0231

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  6 in total

1.  Preliminary experience with umbilical stoma in transumbilical single-port colorectal surgery.

Authors:  A d'Alessandro; N Kari; A Alameh; N Pasquier; A Tarhini; B Vinson Bonnet; R Noun; E Chouillard
Journal:  Tech Coloproctol       Date:  2018-03-06       Impact factor: 3.781

2.  Systematic review of comparing single-incision versus conventional laparoscopic right hemicolectomy for right colon cancer.

Authors:  Xin Liu; Wei-Hong Yang; Zhou-Guang Jiao; Ji-Fu Zhang; Rui Zhang
Journal:  World J Surg Oncol       Date:  2019-11-04       Impact factor: 2.754

3.  A learning curve in using organ retractor for single-incision laparoscopic right colectomy.

Authors:  Toshio Shiraishi; Tetsuro Tominaga; Takashi Nonaka; Kiyoaki Hamada; Masato Araki; Yorihisa Sumida; Hiroaki Takeshita; Hidetoshi Fukuoka; Kazuo To; Kenji Tanaka; Terumitsu Sawai; Takeshi Nagayasu
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

4.  Paratubal Cystectomy in a Pregnant Woman Using the Single-Incision Laparoscopic Surgery (SILS) Technique.

Authors:  Luke William Nelson; Elliot MacKenzie
Journal:  Case Rep Obstet Gynecol       Date:  2022-07-14

Review 5.  Single-incision laparoscopy surgery: a systematic review.

Authors:  Sasan Saeed Far; Sepide Miraj
Journal:  Electron Physician       Date:  2016-10-25

Review 6.  Re-appraisal and consideration of minimally invasive surgery in colorectal cancer.

Authors:  Mahmoud Abu Gazala; Steven D Wexner
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.